MoneyWorks4Me

A decrease in the sales to Rs. 529.37 millions was observed for the quarter ended September 2021. The sales stood at Rs. 658.53 millions during the similar quarter previous year.A big decline of -39.14% was reported for the quarter ended September 2021 to Rs. 56.21  millions from Rs. 92.36 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 83.94 millions from 135.79 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 529.37 658.53 -19.61 1042.06 950.93 9.58 2448.05 2055.11 19.12
Other Income 27.25 13.13 107.54 40.56 22.12 83.36 71.41 52.22 36.75
PBIDT 83.94 135.79 -38.18 167.23 185.99 -10.09 449.80 218.62 105.75
Interest 1.20 0.47 155.32 3.09 0.81 281.48 2.71 4.60 -41.09
PBDT 82.74 135.32 -38.86 164.49 185.18 -11.17 447.39 213.50 109.55
Depreciation 9.74 10.00 -2.60 19.45 19.99 -2.70 40.35 40.61 -0.64
PBT 73.00 125.32 -41.75 145.04 165.19 -12.20 407.04 172.89 135.43
TAX 16.79 32.96 -49.06 34.86 43.17 -19.25 115.32 30.36 279.84
Deferred Tax 0.12 2.66 -95.49 0.06 0.87 -93.10 2.31 -13.97 -116.54
PAT 56.21 92.36 -39.14 110.18 122.02 -9.70 291.72 142.53 104.67
Equity 829.95 780.65 6.32 829.95 780.65 6.32 789.95 780.65 1.19
PBIDTM(%) 15.86 20.62 -23.10 16.05 19.56 -17.95 18.37 10.64 72.72
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..